The Patent Finder

TCR2 Therapeutics Inc.

8 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
May 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 23, 2027
  • 1 fee due Apr 15, 2027
    The maintenance fee for Compositions and Methods for TCR Reprogramming Using Fusion Proteins (US 10,442,849) comes due Apr 15, 2027. Unpaid by Oct 15, 2027, it lapses early.
  • 1 fee due Jun 26, 2027
    The maintenance fee for Compositions and Methods for TCR Reprogramming Using Fusion Proteins (US 11,851,491) comes due Jun 26, 2027. Unpaid by Dec 27, 2027, it lapses early.
  • 1 fee due Oct 23, 2027
    The maintenance fee for Compositions and Methods for TCR Reprogramming Using Fusion Proteins (US 11,965,012) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 8 of 8

PatentTitleStatus Expires Confidence
US 10,358,473Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 10,358,474Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 10,442,849Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 11,028,142Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 11,965,012Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · Medium confidence
In forceMedium confidence
US 10,208,285Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 11,851,491Compositions and Methods for TCR Reprogramming Using Fusion Proteins
In force
 · High confidence
In forceHigh confidence
US 12,773,452Compositions and Methods for TCR Reprogramming Using CD70 Specific Fusion Proteins
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 8: 3 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 12 abandoned

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited